We were delighted to further expand our complete solutions portfolio
in August, with the addition of next generation sequencing reagents.
Through the acquisition of US-based NuGEN Technologies (now renamed
Tecan Genomics), we are now able to better serve this market segment,
combining innovative NGS kits and genomic sample preparation solutions
with our industry-leading automated workstations to provide dedicated
workflow solutions. This expansion complements our existing range
of complete solutions, which has grown significantly in the last few
years, to include smart consumables, solid phase extraction devices and
immunoassays for specialty diagnostics.